Logos Global Management »

Cartesian Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 90k 27.01

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Cartesian Therapeutics

BlackRock
Jpmorgan Chase & Co
Artal Group
MPM Oncology Impact Management
Ikarian Capital
Vanguard Group
State Street Corporation
Geode Capital Management
Logos Global Management
Nuveen Asset Management
Marshall Wace
Sphera Funds Management
Delphi Financial
Charles Schwab Investment Management
Renaissance Technologies

View all funds holding Cartesian Therapeutics